Clinigen Group PLC (LON:CLIN) insider Shaun Edward Chilton sold 100,000 shares of the stock in a transaction dated Friday, October 13th. The stock was sold at an average price of GBX 1,150 ($15.28), for a total value of £1,150,000 ($1,528,036.14).

Clinigen Group PLC (LON:CLIN) traded down 0.26% during mid-day trading on Monday, hitting GBX 1143.00. The company’s stock had a trading volume of 796,532 shares. Clinigen Group PLC has a 52-week low of GBX 695.00 and a 52-week high of GBX 1,175.00. The company’s 50 day moving average is GBX 1,108.08 and its 200-day moving average is GBX 952.65. The stock’s market cap is GBX 1.32 billion.

Clinigen Group PLC (LON:CLIN) last released its quarterly earnings data on Thursday, September 28th. The company reported GBX 41.80 ($0.56) earnings per share for the quarter, topping analysts’ consensus estimates of GBX 41.20 ($0.55) by GBX 0.60 ($0.01). The firm had revenue of £302.30 million during the quarter. Clinigen Group PLC had a return on equity of 0.98% and a net margin of 0.70%.

The firm also recently disclosed a dividend, which will be paid on Friday, December 1st. Stockholders of record on Thursday, November 9th will be paid a GBX 3.40 ($0.05) dividend. This is a positive change from Clinigen Group PLC’s previous dividend of $1.60. The ex-dividend date is Thursday, November 9th. This represents a dividend yield of 0.32%.

TRADEMARK VIOLATION WARNING: “Shaun Edward Chilton Sells 100,000 Shares of Clinigen Group PLC (CLIN) Stock” was originally reported by American Banking News and is the property of of American Banking News. If you are reading this news story on another site, it was illegally stolen and republished in violation of United States and international trademark and copyright legislation. The original version of this news story can be read at

CLIN has been the topic of a number of recent research reports. Peel Hunt increased their price objective on Clinigen Group PLC from GBX 1,015 ($13.49) to GBX 1,200 ($15.94) and gave the stock a “buy” rating in a report on Friday, July 7th. Numis Securities Ltd cut Clinigen Group PLC to an “add” rating and set a GBX 1,100 ($14.62) price target on the stock. in a report on Tuesday, July 18th.

About Clinigen Group PLC

Receive News & Ratings for Clinigen Group PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clinigen Group PLC and related companies with's FREE daily email newsletter.